Product logins

Find logins to all Clarivate products below.


Blog: Clinical trials

Here you will find relevant articles and insight into all Clarivate related products and news.

Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
Biopharma Biotech Clinical trials
Tolebrutinib: when safety concerns override efficacy signals Tolebrutinib: when safety concerns override efficacy signals
Blog February 24, 2026
Tolebrutinib: when safety concerns override efficacy signals
Biopharma Biotech Clinical trials
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
Blog February 24, 2026
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
Biopharma Biotech Clinical trials
Machine curation in action: a new approach to essential tremor epidemiology Machine curation in action: a new approach to essential tremor epidemiology
Blog November 17, 2025
Machine curation in action: a new approach to essential tremor epidemiology
AI Clinical trials Diagnostics
Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium
Blog July 8, 2024
Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium
Clinical research Clinical trials Digital health
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Blog June 21, 2024
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Clinical trials corporate COVID-19

Clinical trials

How a “fail fast” approach can set clinical trials up for success How a “fail fast” approach can set clinical trials up for success
Blog May 26, 2022
How a “fail fast” approach can set clinical trials up for success
clinical trials data clinical trials data
Blog March 17, 2022
Clinical trials and pregnancy: regulators weigh in
Bioinfogate becomes Clarivate Bioinfogate becomes Clarivate
Blog October 25, 2021
Bioinfogate becomes Clarivate
COVID-19: Fighting a global pandemic with innovation COVID-19: Fighting a global pandemic with innovation
Blog October 14, 2021
COVID-19: Fighting a global pandemic with innovation
Top oncology breakthroughs shared at ESMO 2021 Top oncology breakthroughs shared at ESMO 2021
Blog October 7, 2021
Top oncology breakthroughs shared at ESMO 2021
Paradigm-changing primary Phase III data for malignant melanoma: What to expect from Relatlimab in combination with Opdivo Paradigm-changing primary Phase III data for malignant melanoma: What to expect from Relatlimab in combination with Opdivo
Blog June 23, 2021
Paradigm-changing primary Phase III data for malignant melanoma: What to expect from Relatlimab in combination with Opdivo
KEYNOTE-564 paves future role for immunotherapy in adjuvant renal cell carcinoma KEYNOTE-564 paves future role for immunotherapy in adjuvant renal cell carcinoma
Blog June 21, 2021
KEYNOTE-564 paves future role for immunotherapy in adjuvant renal cell carcinoma
Roche’s Tecentriq shows promise in resectable NSCLC: key takeaways for the market Roche’s Tecentriq shows promise in resectable NSCLC: key takeaways for the market
Blog June 18, 2021
Roche’s Tecentriq shows promise in resectable NSCLC: key takeaways for the market
Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021 Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021
Blog June 16, 2021
Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021
Top 10 oncology breakthroughs shared at ASCO 2021 Top 10 oncology breakthroughs shared at ASCO 2021
Blog June 8, 2021
Top 10 oncology breakthroughs shared at ASCO 2021